Epoxiconazole
CAS No. 133855-98-8
Epoxiconazole ( BAS 480F; BAS480F; BAS-480F; EC 406 850 2; EC-406-850-2 )
Catalog No. M27138 CAS No. 133855-98-8
Epoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 37 | Get Quote |
|
25MG | 67 | Get Quote |
|
50MG | 87 | Get Quote |
|
100MG | 141 | Get Quote |
|
200MG | 213 | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEpoxiconazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionEpoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
-
DescriptionEpoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
-
SynonymsBAS 480F; BAS480F; BAS-480F; EC 406 850 2; EC-406-850-2
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
Recptorδ-opioid receptor; μ-opioid receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number133855-98-8
-
Formula Weight329.8
-
Molecular FormulaC17H13ClFN3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFc1ccc(cc1)C1(Cn2cncn2)OC1c1ccccc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mónica García, et al. Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ 1 Receptor Antagonist Clinical Candidate for the Treatment of Pain. J Med Chem. 2020 Oct 16.
molnova catalog
related products
-
DS-2969b
DS-2969b (DS 11960558) is a novel orally active GyrB inhibitor, inhibits the supercoiling activity of C. difficile DNA gyrase with IC50 of 20 ng/mL.
-
Rifabutin
A semisynthetic ansamycin antibiotic with potent antimycobacterial properties.
-
piperacillin
Piperacillin is a semisynthetic penicillin with wide spectrum of antimicrobial activity(particularly pseudomonas strains.